Results 21 to 30 of about 264,219 (265)

Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis

open access: yesCell & Bioscience, 2022
Background Thrombosis and coagulopathy are pervasive pathological features of coronavirus disease 2019 (COVID-19), and thrombotic complications are a sign of severe COVID-19 disease and are associated with multiple organ failure and increased mortality ...
Weiping Ji   +9 more
doaj   +1 more source

Efecto de la vacunación sobre la transmisión intradomiciliaria del SARS-COV-2, provincia de Santa Fe, Argentina, 2021

open access: yesRevista Argentina de Salud Pública, 2021
INTRODUCCIÓN: En 2019, surgió un nuevo coronavirus que causó una pandemia mundial. Durante 2020, se desarrollaron vacunas con aceptable seguridad y eficacia para disminuir complicaciones y muertes.
Lucas Fernando de Candia   +15 more
doaj  

Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus [PDF]

open access: yes, 2014
The Middle East respiratory syndrome coronavirus (MERS-CoV) was first documented in the Kingdom of Saudi Arabia (KSA) in 2012 and, to date, has been identified in 180 cases with 43% mortality.
Alhakeem, Rafat F.   +50 more
core   +1 more source

Comparison of COVID-19 Vaccination Rollout Approaches across Canada

open access: yesHealth Reform Observer - Observatoire des Réformes de Santé, 2023
Across Canada, there were notable differences in the rollout of provincial/territorial COVID-19 vaccination programs, reflecting diverse sociodemographic profiles, geopolitical landscapes, health system designs, and pandemic experiences.
Tiffany Fitzpatrick   +7 more
doaj  

Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study

open access: yeseJHaem, 2021
Introduction Studies that examine the association between sickle cell disease (SCD) and COVID‐19 outcomes are lacking. This study aims to determine whether SCD is a risk factor for severe COVID‐19 infection in regard to the requirement of noninvasive ...
Abdulkarim Abdulrahman   +7 more
doaj   +1 more source

Epidemiological assessment of SARS-CoV-2 reinfection

open access: yesInternational Journal of Infectious Diseases, 2022
Objectives: SARS-CoV-2 vaccination has been shown to reduce infection severity; however, the reinfection frequency among unvaccinated, partially vaccinated, and fully vaccinated individuals remains unclear.
Marwa Almadhi   +6 more
doaj   +1 more source

The evolving coronavirus

open access: yesNew Scientist, 2020
The coronavirus has mutated very little, but as more people are treated or vaccinated it could face pressure to evolve, finds Graham Lawton.
openaire   +2 more sources

Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome [PDF]

open access: yes, 2007
The severe acute respiratory syndrome coronavirus (SARS-CoV) genome is predicted to encode 14 functional open reading frames, leading to the expression of up to 30 structural and non-structural protein products.
Brunn, Albrecht von   +31 more
core   +1 more source

Human monoclonal antibody combination against SARS coronavirus : synergy and coverage of escape mutants [PDF]

open access: yes, 2006
Background: Experimental animal data show that protection against severe acute respiratory syndrome coronavirus (SARS-CoV) infection with human monoclonal antibodies (mAbs) is feasible.
Peiris, Joseph S. M.   +73 more
core   +1 more source

A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes [PDF]

open access: yes, 2012
Copyright @ 2012, American Society for Microbiology.Human coronaviruses are associated with upper respiratory tract infections that occasionally spread to the lungs and other organs.
Lorin, V   +18 more
core   +1 more source

Home - About - Disclaimer - Privacy